1Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
2Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
3Connors Center for Women's Health and Gender Biology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
4Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
5Departments of Psychiatry and Medicine, Harvard Medical School, Boston, MA.
Address correspondence to: Jill M. Goldstein, PhD, Connors Center for Women's Health and Gender Biology, One Brigham Circle, 3rd floor, 1620 Tremont St, Boston, MA 02120. E-mail: [email protected]
Received 20 May, 2016
Revised 30 August, 2016
Accepted 30 August, 2016
J.M.G. had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analyses and interpretations.
Funding/support: The work of this study was supported by the National Institute of Mental Health (R01 MH090291, J.M.G., PI). Additional support for Dr Jacobs's time was provided by ORWH-NICHD BIRCWH K12 HD051959. The Harvard Clinical and Translational Science Center (NIH UL1 RR025758) provided support for serologic acquisition and evaluations.
Financial disclosure/conflicts of interest: D.M.R. has served as a paid consultant for Eli Lilly, Janssen Pharmaceuticals and Biogen Idec. She also serves on the Neurotrack Scientific Advisory Board as a paid member. These associations are not related to this paper. All other authors have no conflicts of interest.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.menopause.org).
